Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Predictive Role of Proteomics in Blood Pressure Response of Hypertensive Patients Undergoing Renal Denervation.

NCT06208501 is registered in ClinicalTrials.gov with Hippocration General Hospital as lead sponsor.

NCT NCT06208501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06208501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Predictive Role of Proteomics in Blood Pressure Response of Hypertensive Patients Undergoing Renal Denervation.
Lead sponsor
Hippocration General Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2023
Completion date
September 1, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, proteomics, renal denervation